Advertisement
Screener

MYRIAD GENETICS, INC. (MYGN) Current State and Local Tax Expense (Benefit)

2.8 / 5 stars · 68/120 Roast Me

MYRIAD GENETICS, INC. Current State and Local Tax Expense (Benefit)

MYRIAD GENETICS, INC. (MYGN) reported Current State and Local Tax Expense (Benefit) of $1.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-24

  • MYRIAD GENETICS, INC. current state and local tax expense (benefit) for fiscal 2025 was $1.10M, a 26.67% decline from fiscal 2024.
  • MYRIAD GENETICS, INC. current state and local tax expense (benefit) for fiscal 2024 was $1.50M, a 16.67% decline from fiscal 2023.
  • MYRIAD GENETICS, INC. current state and local tax expense (benefit) for fiscal 2023 was $1.80M, a 5.26% decline from fiscal 2022.
  • MYRIAD GENETICS, INC. current state and local tax expense (benefit) for fiscal 2022 was $1.90M, a 47.22% decline from fiscal 2021.
Period endCurrent State and Local Tax Expense (Benefit) 6 monthCurrent State and Local Tax Expense (Benefit) 12 monthCurrent State and Local Tax Expense (Benefit) 12 month as first filed
2025-12-31$1.10M
10-K · filed 2026-02-24
2024-12-31$1.50M
10-K · filed 2026-02-24
2023-12-31$1.80M
10-K · filed 2026-02-24
2022-12-31$1.90M
10-K · filed 2025-02-28
2021-12-31$3.60M
10-K · filed 2024-02-28
2020-12-31-$600.00K
10-K · filed 2023-03-01
2020-06-30$4.90M
10-K · filed 2023-03-01
2019-06-30-$100.00K
10-K · filed 2022-02-25
2018-06-30$2.20M
10-KT · filed 2021-03-16
2017-06-30$2.40M
10-K · filed 2019-08-13
2016-06-30$3.40M
10-K · filed 2018-08-24
$3.50M
10-K · filed 2016-08-10
2015-06-30$4.70M
10-K · filed 2017-08-09
2014-06-30$3.50M
10-K · filed 2016-08-10
$3.54M
10-K · filed 2014-08-13
2013-06-30$6.00M
10-K · filed 2015-08-12
$6.02M
10-K · filed 2013-08-14
2012-06-30$4.65M
10-K · filed 2014-08-13
2011-06-30$3.44M
10-K · filed 2013-08-14
2010-06-30$8.51M
10-K · filed 2012-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92